Transit Scientific announced the FDA cleared its support catheter platform for coronary use.
The platform (XO Cross) is indicated for guidewire support during access of the peripheral or coronary vasculature and may also be used for wire exchanges and the delivery of saline solutions or diagnostic contrast agents, according to a company press release.
The company will launch its catheter system (2Fr Coronary XO Cross 014 Microcath) for use with 0.014-in. guidewires in 90 cm, 135 cm, 150 cm and 175 cm lengths.
The platform’s nontapered shaft and tapered polymer tip has a low crossing profile and facilitates coaxial use through any 035 compatible coronary guiding catheter, according to the release.
"The trackability and high-torque response of the XO Cross Platform will help us gain wire access in challenging coronary tortuosity and worst-case calcium and plaque. We've seen great results with XO Cross in our peripheral vascular procedures, so we look forward to using this platform for percutaneous coronary interventions," Vasili Lendel, MD, interventional cardiologist at Arkansas Heart Hospital in Little Rock, Arkansas, said in the release.
Get the latest news and education delivered to your inbox
© 2022 Healio All Rights Reserved.
Get the latest news and education delivered to your inbox
© 2022 Healio All Rights Reserved.